KCM
Knoll Capital Management Portfolio holdings
AUM
$141M
This Quarter Return
+28.25%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$187M
AUM Growth
+$187M
(+29%)
Cap. Flow
+$6.52M
Cap. Flow
% of AUM
3.48%
Top 10 Holdings %
Top 10 Hldgs %
99.93%
Holding
12
New
2
Increased
2
Reduced
4
Closed
1
Top Buys
| 1 |
AMPE
Ampio Pharmaceuticals Inc.
AMPE
|
$5.39M |
| 2 |
VVUS
Vivus Inc
VVUS
|
$4.65M |
| 3 |
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
|
$563K |
| 4 |
Exact Sciences
EXAS
|
$165K |
Top Sells
| 1 |
Genworth Financial
GNW
|
$1.4M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
$1.2M |
| 3 |
ECTE
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
|
$1.11M |
| 4 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$450K |
| 5 |
SQNM
SEQUENOM INC NEW
SQNM
|
$92.1K |
Sector Composition
| 1 | Healthcare | 17.77% |
| 2 | Financials | 1.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDVN
1
DELISTED
MEDIVATION, INC.
MDVN
| $149M | 79.45% | 2,484,101 -20,000 | -0.8% | -$1.2M |
|
|
AMPE
2
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $15.2M | 8.11% | 2,026,998 +718,543 | +55% | +$5.39M |
|
3
Arcturus Therapeutics
ARCT
$462M
| $10.6M | 5.65% | 587,000 | – | – |
|
|
VVUS
4
DELISTED
Vivus Inc
VVUS
| $4.65M | 2.48% | +500,000 | New | +$4.65M |
|
|
5
Genworth Financial
GNW
$3.52B
| $2.7M | 1.44% | 211,000 -109,000 | -34% | -$1.4M |
|
|
SQNM
6
DELISTED
SEQUENOM INC NEW
SQNM
| $2.39M | 1.27% | 893,600 -34,500 | -4% | -$92.1K |
|
|
LUMO
7
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $1.45M | 0.78% | 77,437 +30,000 | +63% | +$563K |
|
|
KERX
8
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $1.01M | 0.54% | 100,000 | – | – |
|
|
CELG
9
DELISTED
Celgene Corp
CELG
| $225K | 0.12% | 27,925 | – | – |
|
|
10
Exact Sciences
EXAS
$8.98B
| $165K | 0.09% | +14,000 | New | +$165K |
|
|
ECTE
11
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
| $123K | 0.07% | 44,445 -400,000 | -90% | -$1.11M |
|
|
ACHN
12
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| – | – | -55,000 | Closed | -$450K |
|